sofosbuvir has been researched along with Hepatic Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brainard, DM; Curtis, C; Lasseter, K; Lawitz, E; Ling, KHJ; Marbury, T; Mathias, A; Mogalian, E; Moorehead, L; Murray, B; Osinusi, A; Perry, R | 1 |
| Bichoupan, K; Branch, AD; Chang, C; Dieterich, DT; Grewal, P; Harty, A; Khaitova, V; Ku, L; Liu, L; Motamed, D; Patel, N; Perumalswami, PV; Schiano, TD; Woodward, M; Yalamanchili, R | 1 |
| Beets, G; Beumont, M; Gutierrez, JA; Jacquemyn, B; Kakuda, TN; Lawitz, E; Luo, D; Ouwerkerk-Mahadevan, S; Picchio, G; Poordad, F; Van Eygen, V; Van Remoortere, P; Vandevoorde, A; Vijgen, L | 1 |
2 trial(s) available for sofosbuvir and Hepatic Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Insufficiency; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Uridine; Young Adult | 2018 |
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Drug-Related Side Effects and Adverse Reactions; Female; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Simeprevir; Sofosbuvir; Treatment Outcome; United States; Valine | 2017 |
1 other study(ies) available for sofosbuvir and Hepatic Insufficiency
| Article | Year |
|---|---|
High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens.
Topics: Aged; Antiviral Agents; Bilirubin; Case-Control Studies; Decision Support Techniques; Female; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Incidence; Male; Middle Aged; Prognosis; Serum Albumin; Serum Albumin, Human; Simeprevir; Sofosbuvir; Survival Analysis | 2016 |